Guiding Cardiac Care During the COVID-19 Pandemic: How Ethics Shapes Our Health System Response.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
08 2020
Historique:
received: 08 05 2020
revised: 27 05 2020
accepted: 02 06 2020
pubmed: 9 6 2020
medline: 26 8 2020
entrez: 8 6 2020
Statut: ppublish

Résumé

The COVID-19 pandemic has raised ethical questions for the cardiovascular leader and practitioner. Attention has been redirected from a system that focuses on individual patient benefit toward one that focuses on protecting society as a whole. Challenging resource allocation questions highlight the need for a clearly articulated ethics framework that integrates principled decision making into how different cardiovascular care services are prioritized. A practical application of the principles of harm minimisation, fairness, proportionality, respect, reciprocity, flexibility, and procedural justice is provided, and a model for prioritisation of the restoration of cardiovascular services is outlined. The prioritisation model may be used to determine how and when cardiovascular services should be continued or restored. There should be a focus on an iterative and responsive approach to broader health care system needs, such as other disease groups and local outbreaks.

Identifiants

pubmed: 32505633
pii: S0828-282X(20)30520-1
doi: 10.1016/j.cjca.2020.06.002
pmc: PMC7270812
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1313-1316

Informations de copyright

Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Références

Can J Cardiol. 2020 Jun;36(6):952-955
pubmed: 32299752
Can J Cardiol. 2020 Jul;36(7):971-976
pubmed: 32380228
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Lancet. 2009 Jan 31;373(9661):423-31
pubmed: 19186274
N Engl J Med. 2020 Jun 11;382(24):2368-2371
pubmed: 32302076

Auteurs

Alice Virani (A)

Department of Medical Genetics, University of British Columbia, British Columbia, Canada. Electronic address: alice.virani@phsa.ca.

Gurmeet Singh (G)

Mazankowski Alberta Hearth Institute, Division of Cardiac Surgery, Departments of Critical Care Medicine and Surgery, University of Alberta, Edmonton, Alberta, Canada.

David Bewick (D)

New Brunswick Heart Centre, Saint John, New Brunswick, Canada.

Chi-Ming Chow (CM)

Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Brian Clarke (B)

Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.

Simone Cowan (S)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Christopher B Fordyce (CB)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Anne Fournier (A)

Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.

Kenneth Gin (K)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Anil Gupta (A)

Trillium Health Partners, University of Toronto, Mississauga, Ontario, Canada.

Sean Hardiman (S)

Cardiac Services BC, Provincial Health Services Authority, Vancouver, British Columbia, Canada.

Simon Jackson (S)

QEII Health Sciences Center, Division of Cardiology, Dalhousie University Halifax, Halifax, Nova Scotia, Canada.

Yoan Lamarche (Y)

Department of Surgery, Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada.

Benny Lau (B)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Jean-François Légaré (JF)

New Brunswick Heart Centre, Saint John, New Brunswick, Canada.

Howard Leong-Poi (H)

Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Samer Mansour (S)

Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.

Ariane Marelli (A)

Department of Medicine, McGill University Health Center, McGill University, Montréal, Québec, Canada.

Ata Quraishi (A)

QEII Health Sciences Center, Division of Cardiology, Dalhousie University Halifax, Halifax, Nova Scotia, Canada.

Idan Roifman (I)

Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Marc Ruel (M)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
QEII Health Sciences Center, Division of Cardiology, Dalhousie University Halifax, Halifax, Nova Scotia, Canada.

Gary Small (G)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Ricky Turgeon (R)

Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

David A Wood (DA)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Shelley Zieroth (S)

University of Manitoba, Winnipeg, Manitoba, Canada.

Sean Virani (S)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Andrew D Krahn (AD)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH